This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Piramal Enterprises Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Nishigandha Naik in Kinase Inhibition
Introduction
Nishigandha Naik is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. Her work focuses on innovative compounds that have the potential to treat various diseases.
Latest Patents
Nishigandha Naik holds a patent for "Substituted imidazoquinoline derivatives as kinase inhibitors." This invention relates to substituted imidazo[4,5-c]quinoline derivatives, which are defined by specific chemical formulas. The compounds are designed for the treatment of diseases mediated by kinases, especially proliferative diseases such as cancer. Additionally, these compounds can be utilized in treating inflammatory diseases and disorders related to angiogenesis.
Career Highlights
Nishigandha Naik is associated with Piramal Enterprises Limited, where she applies her expertise in drug development. Her innovative approach has led to advancements in the pharmaceutical industry, particularly in the area of targeted therapies.
Collaborations
Some of her notable coworkers include Sanjay Kumar and Rajiv Sharma, who contribute to her research and development efforts. Their collaboration enhances the potential for groundbreaking discoveries in the field.
Conclusion
Nishigandha Naik's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to kinase inhibitors represent a significant advancement in the treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile